Casal, A.; Leiro-Fernández, V.; Villar-Aguilar, L.; Casal-Guisande, M.; Mosteiro-Añón, M.; Botana-Rial, M.; Represas-Represas, C.; Torres-Durán, M.; Fernández-Villar, A.
Lung Toxicity from Immune Checkpoint Inhibitors: A Diagnostic Approach. J. Clin. Med. 2025, 14, 6133.
https://doi.org/10.3390/jcm14176133
AMA Style
Casal A, Leiro-Fernández V, Villar-Aguilar L, Casal-Guisande M, Mosteiro-Añón M, Botana-Rial M, Represas-Represas C, Torres-Durán M, Fernández-Villar A.
Lung Toxicity from Immune Checkpoint Inhibitors: A Diagnostic Approach. Journal of Clinical Medicine. 2025; 14(17):6133.
https://doi.org/10.3390/jcm14176133
Chicago/Turabian Style
Casal, Ana, Virginia Leiro-Fernández, Laura Villar-Aguilar, Manuel Casal-Guisande, Mar Mosteiro-Añón, Maribel Botana-Rial, Cristina Represas-Represas, MarÃa Torres-Durán, and Alberto Fernández-Villar.
2025. "Lung Toxicity from Immune Checkpoint Inhibitors: A Diagnostic Approach" Journal of Clinical Medicine 14, no. 17: 6133.
https://doi.org/10.3390/jcm14176133
APA Style
Casal, A., Leiro-Fernández, V., Villar-Aguilar, L., Casal-Guisande, M., Mosteiro-Añón, M., Botana-Rial, M., Represas-Represas, C., Torres-Durán, M., & Fernández-Villar, A.
(2025). Lung Toxicity from Immune Checkpoint Inhibitors: A Diagnostic Approach. Journal of Clinical Medicine, 14(17), 6133.
https://doi.org/10.3390/jcm14176133
